MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-025-03985-7

Медицинская библиотека · Scientific reports · 2025

The CRP-albumin-lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system.

Zhao Hong, Yin Bing, Li Xiang-Rui, Liu Xiao-Yue, Bu Zhao-Ting, Shi Han-Ping

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

Reliable biomarkers are critical for improving overall survival (OS) and guiding therapeutic strategies in liver cancer. This study evaluated the CRP-albumin-lymphocyte (CALLY) index-a composite indicator of systemic inflammation, nutritional status, and immune function-as a prognostic tool for liver cancer, comparing its predictive utility to the established TNM staging system. A retrospective cohort of 388 patients with histologically confirmed liver cancer was analyzed using data from the Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) database. Kaplan-Meier survival analysis, restricted cubic spline (RCS) functions, and multivariate Cox regression models were utilized to determine the prognostic significance of the CALLY index. A nomogram was constructed incorporating the CALLY index, age, and TNM stage to estimate 1-, 2-, 3-year OS. The model's performance was benchmarked against the TNM staging system using time-dependent receiver operating characteristic (ROC) curves and Decision curve analysis (DCA). Multivariate Cox regression analysis demonstrated that the CALLY index was independently associated with OS in patients with liver cancer [Hazard ratio (HR) = 0.57, 95% confidence interval (CI) 0.39-0.83, P =0.003]. The prognostic value of the CALLY index was superior to that of the TNM staging system (C-index = 0.621, 95% CI 0.572-0.669, P < 0.001). Compared with the traditional TNM staging system, the prognostic nomogram incorporating the CALLY index, age, and TNM stage demonstrated higher accuracy in predicting 1-, 2-, and 3-year OS in patients with liver cancer (1-year: 0.705 vs. 0.644; 2-year: 0.698 vs. 0.66; 3-year: 0.6499 vs. 0.6079). The CALLY index is a robust prognostic biomarker for liver cancer, offering enhanced predictive accuracy over traditional staging methods. Its incorporation into a predictive nomogram may facilitate personalized treatment strategies, ultimately improving patient outcomes.

Для цитирования: Zhao Hong, Yin Bing, Li Xiang-Rui, Liu Xiao-Yue, Bu Zhao-Ting, Shi Han-Ping. The CRP-albumin-lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system.. Scientific reports. 2025. DOI: 10.1038/s41598-025-03985-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.